Oncopeptides
Gunilla Huledal is a highly experienced professional in clinical pharmacology, currently serving as a Senior Clinical Pharmacology Scientist at Oncopeptides AB since April 2021. Prior to this role, Gunilla Huledal held similar positions at Sobi - Swedish Orphan Biovitrum AB and Novartis, demonstrating a strong background in pharmacokinetics and pharmacodynamics. Gunilla Huledal's career also includes significant tenure at AstraZeneca R&D and Pharmacia, as well as experience as a pharmacokinetic assessor at the Medical Products Agency. Academically, Gunilla Huledal earned a MSc (Pharm) from Uppsala University and furthered knowledge at Lund University in 2013.
This person is not in any offices